Therefore, the genetic evaluation of follistatin should be performed with regard to its association with androgenic characteristics of PCOS and regardless of racial differences, because the inconsistency of previous findings is mainly due to ethnic background of participants. This evidence concerns the gene FST and polycystic ovary syndrome.